NEWSFOCUSDOCUMENTSEDITOR’S PICKMAGAZINEABOUT
Subscribe to SSM Digest
Your email:
SEARCH
PUBLISHED BY
EXPLORE THE MAGAZINE
AVAILABLE NOW
Also Available in Chinese - 也可在中国语文
TODAY’S SPACE WEATHER
UPCOMING REENTRIES
COLLISION RISK TODAY
ISS TRACKER
Gadgets powered by Google
VISITOR GLOBE
FOCUS
ISS Research Advances Cancer Treatment
MAY 3, 2012 21:36 STAFF WRITERS 0 COMMENTS
New EVA Planned to Finish Power Module Installation
Singer Sarah Brightman May Be Next Space Tourist
ISS Crew Gears Up for Spacewalks
Space Bacteria, Plants Hold Lessons for Earth
Dr. Morrison with MEPS flight hardware ready to pack for the International Space Station UF-2 mission (Credits: NASA).
Source: NASA
Humanity is on the constant search for improvements in cancer treatments, and the International Space Station has provided a microgravity platform that has enabled advancements in the cancer treatment process.
The oncology community has a recent history of using different microencapsulation techniques as an approach to cancer treatment. Microencapsulation is a single step process that forms tiny liquid-filled, biodegradable micro-balloons containing various drug solutions that can provide better drug delivery and new medical treatments for solid tumors and resistant infections. In other words, by using microcapsules containing antitumor treatments and visualization markers, the treatment can be directed right to the tumor, which has several benefits over systemic treatment such as chemotherapy. Testing in mouse models has shown that these unique microcapsules can be injected into human prostate tumors to actually inhibit tumor growth or can be injected following cryo-surgery (freezing) to improve the destruction of the tumors much better than freezing or local chemotherapy alone. The microcapsules also contain a contrast agent that enables C-T, X-ray or ultrasound imaging to monitor the distribution within the tissues to ensure that the entire tumor is treated when the microcapsules release their drug contents.
Schematic of the Pulse Flow Microencapsulation System (Credits: NASA).
The Microencapsulation Electrostatic Processing System-II experiment, or MEPS-II, led by Dennis Morrison, Ph.D. (retired), at NASA Johnson Space Center, was performed on the station in 2002 and included innovative encapsulation of several different anti-cancer drugs, magnetic triggering particles, and encapsulation of genetically engineered DNA. The experiment system improved on existing microencapsulation technology by using microgravity to modify the fluid mechanics, interfacial behavior, and biological processing methods as compared to the way the microcapsules would be formed in gravity.
In effect, the MEPS-II system on the station combined two immiscible liquids in such a way that surface tension forces (rather than fluid shear) dominated at the interface of the fluids. The significant performance of the space-produced microcapsules as a cancer treatment delivery system motivated the development of the Pulse Flow Microencapsulation System, or PFMS, which is an Earth-based system that can replicate the quality of the microcapsules created in space.
As a result of this space station research, the results from the MEPS-II experiments have provided new insight into the best formulations and conditions required to produce microcapsules of different drugs, particularly special capsules containing diagnostic imaging materials and triggered release particles. Co-encapsulation of multiple drugs and Photodynamic Therapy, or PDT, drugs has enabled new engineering strategies for production of microcapsules on Earth designed for direct delivery into cancer tissues. Other microcapsules have now been made for treatment of deep tissue infections and clotting disorders and to provide delivery of genetically engineered materials for potential gene therapy strategies. Microcapsules that were made on the space station and are targeted at inhibiting the growth of human prostate tumors have been successfully demonstrated in laboratory settings. Although Morrison’s team had performed several similar microencapsulation experiments on space shuttle missions, because of the space station’s ability to support long-term experiments, more progress was made by the eight microencapsulation experiments conducted on the station in 2002 than from the 60+ prior experiments conducted on the four space shuttle missions — STS-77, STS-80, STS-95 and STS 107.
Microencapsulation containing anti-tumor drugs made on the space station (Credits: NASA).
Benefits of Space Station Research
The microgravity environment on the station was an enabling environment that led the way to better methods of microcapsule development on Earth. The capability to perform sequential microencapsulation experiments on board the station has resulted in new, Earth-based technology for making these unique microballoons that provide sustained release of drugs over a 12–14 day period. The station research led directly to five U.S. patents that have been licensed by NASA and two more that are pending. NuVue Therapeutics, Inc., is one of several commercial companies that have licensed some of the MEPS technologies and methods to develop new applications, such as innovative ultrasound enhanced needles and catheters that will be used to deliver the microcapsules of anti-tumor drugs directly to tumor sites. More recent research uses a new device for freezing tumors (“cryo-ablation”) followed by ultrasound-guided deposition of the multi-layered microcapsules containing different chemotherapy drugs outside the freeze zone within a human prostate or lung tumor. In a 28-day study, combination therapy resulted in retarding tumor growth 78 percent and complete tumor regression of up to 30 percent after only three weekly injections of microencapsulated drug at tiny quantities that should not have slowed down tumor growth by more than 5–10 percent. NuVue Technologies, Inc., has now obtained two U.S. patents based on the combination therapy that includes the delivery of the NASA-type microcapsules. Upon securing funding, clinical trials to inject microcapsules of anti-tumor drugs directly into tumor sites will begin at MD Anderson Cancer Center in Houston and the Mayo Cancer Center in Scottsdale, Ariz.
Other potential uses of this microencapsulation technology include microencapsulation of genetically engineered living cells for injection or transplantation into damaged tissues, enhancement of human tissue repair, and real-time microparticle analysis in flowing sample streams that would allow petrochemical companies to monitor pipeline volume flow.
Boeing X-37C Crew Vehicle
Crew carrying X-37C conceptual study (Credits: AIAA/Grantz/Boeing). As already announced by the Space Safety Magazine, Boeing is studying an X-37B derivative for cargo and crew transfer to and from the ISS. Arthur Grantz, chief ...
73 Views
Russia Spends $1 Billion on New Cosmodrome While Agency Investigation Continues
Putin (second from right) inspecting a model of the new cosmodrome (Credits: cosmodromegovernment.ru). Russia began construction of the Vostochny Cosmodrome in 2011. The Cosmodrome, which is slated for completion in 2018, is intended to ...
68 Views
Chinese Use Space Radiation to Mutate Food Crops
A cucumber derived from space irradiated seeds (Credits: Guandong Academy of Agricultural Sciences). Exposure to radiation is one of the well-studied hazards of spaceflight. But what if you could turn that hazard to advantage? ...
60 Views
Coronal Mass Ejection Causes Moderate Geomagnetic Storm
CME shockwave and accompanying ground current observed September 3 (Credits: Spaceweather.com). On August 31, a spectacular solar filament eruption released a coronal mass ejection (CME) that struck Earth on September 3. The 500 km/s CME ...
53 Views
NASA Funds Study of Sideways Flying Supersonic Plane
A rendition of the Supersonic Bidirectional Flying Wing (Credits: Gecheng Zha). NASA has approved a $100,000 grant for development of a supersonic plane concept pioneered by Gecheng Zha, a professor at the University of Miami. Called ...
46 Views
Endeavour's Final Journey Marred by Tree Chopping Controversy
Endeavour's route from Los Angeles Airport to the California Science Center (Credits: GoogleMaps). Since the ending of NASA's Space Shuttle program in 2011, the remaining shuttles and their test models have been dispersing to final resting ...
44 Views
Neil Armstrong's Insurance Policy
Apollo 11 astronaut cover (Credits: collectspace.com). Being an astronaut is a risky business, especially so in the pioneer days of Mercury through Apollo. With all the safety precautions space agencies take, there's still no guarantee that an ...
43 Views
Meet the Water Bear
A magnified Water Bear in its natural habitat (Credits: Mother Board). The Water Bear, more formally known as the Tardigrade, is the only known animal able to survive in outer space. Water Bears undergo an ...
38 Views
Russian Shame after Proton Failure: Government Gives Roscosmos One Month for Substantial Changes
The chief of the Russian Space Agency (Roscosmos) Vladimir Popovkin probably hasn't had the best month of his life. After the August 6 Proton failure caused a loss of two telecommunication satellites, he might ...
33 Views
Staff Writers
More Posts
Share this:
Share
No comments:
Post a Comment